What fools these mortals be: The Tipline for 8 September 2020
We hope you all had a splendid three-day weekend. Before everyone logged off on Friday, the Federal Trade Commission announced that it approved a final order settling charges that AbbVie’s $63 billion acquisition of Allergan would violate federal antitrust law. Commissioner Rohit Chopra took another dig at the settlement, which he voted against back in May. “Public input received during the comment period from across the country also called into question the appropriateness of this decision, but the FTC went ahead anyway,” he tweeted.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10